Skip to main content
Caplight Logo









Rapid Nexus Nanotech Wound Solutions, Inc.

Rapid Nexus Nanotech Wound Solutions, Inc.

Private
Brea, CaliforniaHealthcare & Life Scienceshttps://rapidnexus.com/

Last Round

Seed

Sep 23, 2025

Total Funding Raised

$3.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Rapid Nexus Nanotech Wound Solutions, Inc. is a medical technology company that develops regenerative wound healing solutions, including the Hemastyl gel and Periwound NerveStim device, to treat chronic wounds and prevent amputations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

wound careregenerative therapymedical devicelimb preservationneuromuscular electrical stimulationNMESchronic wound treatmentperipheral neuropathywound healing geladvanced wound careelectrotherapybiotechdefense health techVA medical supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rapid Nexus Nanotech Wound Solutions, Inc. Comparables

Compare Rapid Nexus Nanotech Wound Solutions, Inc. with similar companies based on industry and business-model similarity.

Rapid Nexus Nanotech Wound Solutions, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuo Therapeutics Inc
73%
Imbed Biosciences
73%
Conexeu Sciences Inc.
68%

Rapid Nexus Nanotech Wound Solutions, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 23, 2025

Key People

Founding team and executive leadership

Christine Pasciak

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 329% MoM.

  • Jun 22, 2026

    Monthly visitors increased 138% MoM, reaching 347.

Rapid Nexus Nanotech Wound Solutions, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rapid Nexus Nanotech Wound Solutions, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rapid Nexus Nanotech Wound Solutions, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBrea, California
Employee Range6
Year Founded2020
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?